S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Fund/BVF Partners/Q2 2020

BVF Partners

Periodo: Q2 2020 Β· Depositato: 2020-08-14
Vedi su SEC EDGAR β†—
AUM
$1.62B
Valore totale del portafoglio
Posizioni
57
Titoli dichiarati
Prima Posizione
SWTX
5.9% $96.0M
Var. Trimestrali
+8 / -8
nuovi Β· usciti
⚠️Informativa sui Depositi 13F

I dati AUM mostrati sono calcolati sommando il valore di mercato dichiarato di tutte le posizioni nei depositi SEC 13F-HR β€” non rappresentano il patrimonio effettivo gestito dal fondo.

  • Escluse liquiditΓ , obbligazioni, private equity, posizioni corte e azioni estere non soggette all'obbligo di dichiarazione.
  • Per le opzioni PUT e CALL, il Valore dichiarato Γ¨ il valore nozionale delle azioni sottostanti β€” non il premio pagato. CiΓ² sovrastima significativamente il capitale effettivamente a rischio.
  • Il patrimonio reale del fondo Γ¨ tipicamente superiore e include strategie, strumenti e posizioni che non compaiono mai in un 13F.
  • I depositi 13F riguardano i gestori istituzionali con β‰₯$100M in titoli 13F. Le posizioni riflettono le partecipazioni a fine trimestre, divulgate entro 45 giorni dalla fine del periodo.

Dati provenienti da SEC EDGAR. Questo tracker Γ¨ a scopo puramente informativo e non costituisce consulenza finanziaria.

Partecipazioni in Portafoglio

Prime 30 posizioni

⚠️ Performance % calcolata dalla data di deposito ( 2020-08-14) si riferisce al titolo sottostante β€” non al P&L del derivato.
TickerEmittenteNozionalePortafoglio %Al DepositoOra (Fine Giornata)Dal DepositoAllocazione
SWTXSPRINGWORKS THERAPEUTICS INC$96.0M5.92%β€”β€”
5.9%
PRNBPRINCIPIA BIOPHARMA INC$88.8M5.47%β€”β€”
5.5%
ARGXARGENX SE$87.8M5.42%$225.23$939.68+317.2%
5.4%
IONSIONIS PHARMACEUTICALS INC$83.9M5.17%$58.96$81.80+38.7%
5.2%
MRUSMERUS N V$81.9M5.05%β€”β€”
5.0%
XOMAXOMA CORP DEL$79.6M4.91%$19.76$43.00+117.6%
4.9%
ACIUAC IMMUNE SA$76.2M4.70%$6.73$2.51-62.7%
4.7%
XNCRXENCOR INC$67.0M4.13%$32.39$15.00-53.7%
4.1%
RPTXREPARE THERAPEUTICS INC$60.3M3.72%β€”β€”
3.7%
REPLREPLIMUNE GROUP INC$57.5M3.55%$24.85$11.58-53.4%
3.5%
FPRXFIVE PRIME THERAPEUTICS INC$48.7M3.00%β€”β€”
3.0%
RCUSARCUS BIOSCIENCES INC$46.6M2.87%$24.74$30.33+22.6%
2.9%
IDYAIDEAYA BIOSCIENCES INC$45.9M2.83%$14.21$37.65+164.9%
2.8%
KURAKURA ONCOLOGY INC$45.3M2.79%$16.30$11.10-31.9%
2.8%
XENEXENON PHARMACEUTICALS INC$44.1M2.72%$12.54$60.96+386.1%
2.7%
PTGXPROTAGONIST THERAPEUTICS INC$41.8M2.58%$17.66$131.62+645.3%
2.6%
CALACALITHERA BIOSCIENCES INC$37.4M2.31%$105.60$0.00
2.3%
SNDXSYNDAX PHARMACEUTICALS INC$36.6M2.26%$14.82$21.82+47.2%
2.3%
CLDXCELLDEX THERAPEUTICS INC NEW$35.6M2.20%$13.00$38.37+195.2%
2.2%
MTEMXXXXMOLECULAR TEMPLATES INC$29.6M1.83%β€”β€”
1.8%
ANABANAPTYSBIO INC$28.9M1.78%$14.89$63.42+325.9%
1.8%
GLYCGLYCOMIMETICS INC$27.2M1.68%β€”β€”
1.7%
IMVTIMMUNOVANT INC$26.5M1.63%$24.35$38.79+59.3%
1.6%
CTMXCYTOMX THERAPEUTICS INC$25.9M1.60%$8.33$3.82-54.1%
1.6%
RVMDREVOLUTION MEDICINES INC$25.2M1.55%$31.57$189.24+499.4%
1.6%
RNACSELECTA BIOSCIENCES INC$23.6M1.45%$85.20$10.59-87.6%
1.4%
STROSUTRO BIOPHARMA INC$18.4M1.13%$77.60$30.43-60.8%
1.1%
OVIDOVID THERAPEUTICS INC$17.6M1.09%$7.37$2.69-63.5%
1.1%
CALTCALLIDITAS THERAPEUTICS AB$17.5M1.08%β€”β€”
1.1%
MEIPXXXXMEI PHARMA INC$17.1M1.05%β€”β€”
1.1%

AttivitΓ  Trimestre su Trimestre

Q2 2020 vs. Q1 2020

Nuove Posizioni (8)

TickerEmittenteNozionaleDal Deposito
RPTXREPARE THERAPEUTICS INC$60.3M
CLDXCELLDEX THERAPEUTICS INC NEW$35.6M+195.2%
CALTCALLIDITAS THERAPEUTICS AB$17.5M
FBRXFORTE BIOSCIENCES INC$14.3M
CFRXCONTRAFECT CORP$10.2M
EVLOEVELO BIOSCIENCES INC$6.4M
CRISCURIS INC$4.4M
EXELEXELIXIS INC$0.4M

Posizioni Chiuse (8)

TickerEmittenteNozionale
CYTKCYTOKINETICS INC$46.4M
MRSNMERSANA THERAPEUTICS INC$13.8M
KZRKEZAR LIFE SCIENCES INC$6.8M
AKROAKERO THERAPEUTICS INC$6.0M
PRVLPREVAIL THERAPEUTICS INC$5.3M
ALPNALPINE IMMUNE SCIENCES INC$3.3M
LKFTGALAPAGOS NV$1.5M
EIGREIGER BIOPHARMACEUTICALS INC$0.5M

Aumentate (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
RCUSARCUS BIOSCIENCES INC$46.0M+4780.8%+22.6%
ARGXARGENX SE$84.5M+1460.0%+317.2%
STROSUTRO BIOPHARMA INC$13.5M+398.1%-60.8%
PTGXPROTAGONIST THERAPEUTICS INC$36.9M+241.9%+645.3%
NVUSNOVUS THERAPEUTICS INC$0.6M+160.7%
IDYAIDEAYA BIOSCIENCES INC$40.6M+151.1%+164.9%
RNACSELECTA BIOSCIENCES INC$14.9M+129.8%-87.6%
GMDAQGAMIDA CELL LTD$6.8M+114.4%

Ridotte (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
SNSSSUNESIS PHARMACEUTICALS INC$-1.9M-58.1%
PHATPHATHOM PHARMACEUTICALS INC$-6.9M-52.4%
PIRSPIERIS PHARMACEUTICALS INC$-3.7M-47.0%
RVMDREVOLUTION MEDICINES INC$-5.4M-42.9%+499.4%
FWPAYFORWARD PHARMA A/S$-1.4M-30.1%
IONSIONIS PHARMACEUTICALS INC$-8.1M-26.8%+38.7%
CALACALITHERA BIOSCIENCES INC$-5.0M-25.8%
MTEMXXXXMOLECULAR TEMPLATES INC$-8.2M-24.6%
← Torna agli Hedge Fund